Risk factors for medication nonadherence in older adults with cognitive impairment who live alone

International Journal of Geriatric Psychiatry
Thulasi ThiruchselvamMary C Tierney

Abstract

The aim of this study was to prospectively examine the influence of cognitive, medical, behavioral, and social risk factors on medication nonadherence in community-dwelling older adults with cognitive impairment. A sample of 339 elderly participants with cognitive impairment, who lived alone and took at least one medication, underwent baseline assessment which included the five subscales of the Dementia Rating Scale (DRS), number of medications, retrospective medication nonadherence, amount of formal and informal assistance, functional impairment, depression, perception of social resources, comorbidity, and alcohol consumption. The outcome was medication nonadherence during the 12-month prospective period as reported by the participants' primary care physicians and caregivers at three-month intervals. Fifty-nine participants (17.4%) had, at least, one report of medication nonadherence. Logistic regression analyses indicated for every point increase on the DRS Conceptualization subscale (OR = 1.14; 95% CI = 1.02-1.27), there was a 14% increase in the odds of nonadherence. For every point increase on the DRS Memory subscale (OR = 0.89; 95% CI = 0.81-0.97) and DRS Initiation/Perseveration subscale (OR = 0.93; 95% CI = 0.87-1.00), ...Continue Reading

References

Jan 1, 1982·Journal of Community Health·J Y GreeneJ J Mamlin
Jan 1, 1982·Journal of Psychiatric Research·J A YesavageV O Leirer
Jul 1, 1994·Journal of Gerontological Nursing·V ConnR Miller
Jan 1, 1996·European Journal of Clinical Pharmacology·T NikolausG Schlierf
Nov 13, 1996·JAMA : the Journal of the American Medical Association·C HoffmanH Y Sung
Oct 31, 1997·The Gerontologist·R W MorrellM Martin
Sep 16, 1998·Clinical Therapeutics·R Balkrishnan
Oct 1, 1998·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·J McCuskerS Trépanier
Jun 26, 2001·British Journal of Clinical Pharmacology·I BaratE M Damsgaard
Jul 27, 2001·Journal of Clinical Epidemiology·E W SteyerbergJ D Habbema
Dec 26, 2001·Clinical Pharmacology and Therapeutics·M SalasB H Stricker
Jan 5, 2002·European Journal of Clinical Pharmacology·J OkunoS Tomura
Jan 16, 2002·JAMA : the Journal of the American Medical Association·David W KaufmanAllen A Mitchell
Jul 23, 2002·JAMA : the Journal of the American Medical Association·Joshua S BennerJerry Avorn
Jul 23, 2002·Journal of General Internal Medicine·Philip S WangJerry Avorn
Feb 7, 2003·Journal of the International Neuropsychological Society : JINS·Agnes S ChanLinda Lam
Sep 3, 2004·Journal of the American Geriatrics Society·Mary C TierneyRory H Fisher
Mar 17, 2005·JAMA : the Journal of the American Medical Association·Daniela FialováUNKNOWN AdHOC Project Research Group
Aug 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Adriana S A AndradeJustin C McArthur
Nov 17, 2005·The Annals of Pharmacotherapy·Jennie L YeeDonald H Schreiber
Nov 22, 2005·Applied Nursing Research : ANR·Kathleen Collins Insel, Lois Cole
Dec 2, 2005·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Claudia CooperGill Livingston
Feb 25, 2006·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Kathleen InselAurelio Figueredo
May 4, 2006·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Mary GanguliHiroko H Dodge
Nov 3, 2006·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Scott A LynessEvelyn L Teng
Feb 3, 2007·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Mary C TierneyAlex Kiss
Jan 24, 2009·The American Journal of Geriatric Pharmacotherapy·Gary P StoehrMary Ganguli
Jan 13, 2010·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Carol S StilleyChristopher M Ryan

❮ Previous
Next ❯

Citations

Feb 28, 2013·European Journal of Clinical Pharmacology·Linda BrewerDavid Williams
Jan 22, 2014·Wiener klinische Wochenschrift·Christoph StrehblowPeter Fasching
Aug 21, 2013·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Laura O WrayChristina L Vair
Oct 23, 2016·Research in Social & Administrative Pharmacy : RSAP·Zain K Hudani, Carlos H Rojas-Fernandez
Jun 5, 2012·The American Journal of Geriatric Pharmacotherapy·Noll L CampbellMichael D Murray
Nov 4, 2015·International Journal of Medical Informatics·Catherine H OlsonBonnie L Westra
Aug 29, 2016·Journal of Alzheimer's Disease : JAD·Lea StevnsborgGunhild Waldemar
Oct 21, 2016·Geriatrics & Gerontology International·Angela Frances YapYu Heng Kwan
May 26, 2017·Journal of Pharmacy Practice·Najwan El-SaifiHaitham Tuffaha
Sep 27, 2014·Acta Medica (Hradec Králové)·Jan LužnýLubica Juríčková
Jul 12, 2018·Expert Opinion on Drug Safety·Tesfahun C EshetieLisa M Kalisch Ellett
Jun 6, 2020·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Xingyan YuYang Lü
Feb 24, 2015·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Colleen J MaxwellNathan Herrmann
Mar 30, 2017·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Johanna AustinJeffrey Kaye
Sep 25, 2018·Expert Opinion on Pharmacotherapy·Amanda CalhounGeorge T Grossberg
Dec 31, 2020·Dementia and Neurocognitive Disorders·Yeonsil MoonHojin Choi
Feb 21, 2021·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Jakub Droś, Aleksandra Klimkowicz-Mrowiec
Apr 3, 2021·Innovation in Aging·Amy Rosenwohl-MackElena Portacolone
Jul 3, 2021·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Sayuri SuwaAtsuko Shimamura

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.